期刊文献+

BCYRN1调控miR-503通过Notch1信号通路对肺癌迁移和侵袭的影响 被引量:5

Effects of BCYRN1 on miR-503 on migration and invasion of lung cancer by Notch1 pathway
下载PDF
导出
摘要 目的:探讨BCYRN1调控miR-503通过Notch1信号通路对肺癌迁移和侵袭的影响机制。方法:q PCR检测不同肺癌细胞株中BCYRN1和miR-503的表达情况;免疫荧光和q PCR检测慢病毒BCYRN1+siRNA转染肺癌细胞的转染效率;双荧光素酶报告基因检测BCYRN1与miR-503的相互作用;Transwell侵袭实验和划痕实验检测沉默BCYRN1后肺癌细胞侵袭和迁移能力的变化;Western blot检测沉默BCYRN1后Notch1信号通路蛋白的表达情况;裸鼠皮下成瘤检测沉默BCYRN1后肺癌细胞裸鼠体内成瘤能力的影响。结果:在肺癌细胞H1299中BCYRN1表达水平最高,miR-503的表达水平相对较高;免疫荧光及mRNA水平证明BCYRN1+siRNA慢病毒可以有效转染进入H1299细胞内;BCYRN19能与miR-503的3'-UTR特异性结合;沉默BCYRN1可以抑制肺癌H1299细胞的侵袭和迁移能力;沉默BCYRN1后Notch1通路蛋白表达情况相应下调;与NC组相比,BCYRN1-siRNA组荷瘤小鼠肿瘤体积和重量都明显减小。结论:BCYRN1可以靶向调节miR-503通过Notch1信号通路影响肺癌H1299细胞的侵袭和迁移能力。 Objective: To investigate the mechanism of BCYRN1 regulating miR-503 through Notch1 signaling pathway in the migration and invasion of lung cancer. Methods: The expression of BCYRN1 and miR-503 in different lung cancer cell lines were detected by q PCR. Immunofluorescence and q PCR were used to detect the transfection efficiency of lentivirus BCYRN1 + siRNA transfected lung cancer cells. Double luciferase reporter gene was used to detect the interaction between BCYRN1 and miR-503. Transwell invasion test and scratch test were used to detect the invasion and migration of lung cancer cells after silencing BCYRN1. Western blot was used to detect the expression of Notch1 signaling pathway silence BCYRN1. The effect of silencing BCYRN1 on lung cancer cells in nude mice was measured by subcutaneous tumor formation in nude mice. Results: The expression level of BCYRN1 was the highest in lung cancer cell H1299,and the expression level of miR-503 was relatively high. Immunofluorescence and mRNA levels demonstrated that BCYRN1 + siRNA lentivirus could be effectively transfected into H1299 cells; BCYRN19 binds specifically to the 3'-UTR of miR-503; silencing BCYRN1 could inhibit the invasion and migration of lung cancer H1299 cells; the expression of Notch1 pathway protein was down-regulated after silencing BCYRN1. Compared with NC group,tumor volume and weight of BCYRN1-siRNA group were significantly decreased. Conclusion: BCYRN1 can target the regulation of miR-503 through Notch1 signaling pathway in the invasion and migration of lung cancer H1299 cells.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2017年第10期1453-1457,1463,共6页 Chinese Journal of Immunology
基金 国家自然科学基金(No.31301135) 河南省自然科学基金(No.162300410211) 河南省科技攻关计划项目(No.201203068)
关键词 BCYRN1 肺癌 miR-503 TRANSWELL BCYRN1 Lung cancer miR-503 Transwell
  • 相关文献

参考文献2

  • 1吴一龙,王长利,廖美琳,陆舜,周彩存,傅小龙,钟文昭,毛伟敏,程颖,卢铀,刘云鹏,王洁,黄诚,冯继锋,周清华,蒋国樑,王俊,王绿化,陈晓媛,马胜林,王群,张力,王震,白春学,常建华,陈刚,陈海泉,陈克能,程刚,崔久嵬,范云,顾春东,韩宝惠,侯梅,胡成平,胡艳萍,焦顺昌,李峻岭,李伟雄,梁军,刘晓晴,马智勇,乔贵宾,申屠阳,宋启斌,宋恕平,宋向群,宋勇,王建军,王思愚,伍钢,熊建萍,许林,杨衿记,杨学宁,于丁,于世英,张贺龙,张力,张绪超,张沂平,赵明芳,赵琼,周建英,朱广迎.明智选择:常见的肺癌治疗决策[J].循证医学,2014,14(3):129-134. 被引量:6
  • 2张军旗,祝德.长链非编码RNA MALAT1与非小细胞肺癌患者肿瘤复发和预后的相关性研究[J].广西医科大学学报,2016,33(3):459-463. 被引量:13

二级参考文献31

  • 1Zhong R, Teng J, Han B, et al. Dendritic cells combining with cytokine-indueed killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer[J]. Cancer Immunol Immunother, 2011,60(10) : 1497-1502.
  • 2Zhong R, Han B, Zhong H. A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients[J ]. Tumour Biol, 2014,35 (2) : 987-994.
  • 3Yang L, Ren B, Li H, et al. Enhanced antitumor effects of DC- activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients [J]. Cancer Immunol Immunother, 2013,62(1) :65-73.
  • 4Kimura H, Yamaguchi Y. Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer[J]. Lung Cancer, 1995,13(1) :31-44.
  • 5Kimura H1, Yamaguehi Y. A phase Ⅲ randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma [J]. Cancer, 1997,80( 1 ) : 42-49.
  • 6Yano T, Sugio K, Yamazaki K,et al. Postoperative adjuvant adoptive immunotherapy with lymph node-LAK cells and IL-2 for pathologic stage I non-small cell lung cancer [J]. Lung Cancer, 1999,26(3) : 143-148.
  • 7Ratto GB, Zino P, Mirabelli S, et al. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma[J]. Cancer, 1996,78(2) :244-251.
  • 8Wu C, Jiang J, Shi L, et al. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer [J]. Anticancer Res, 2008,28(6B) :3997-4002.
  • 9Li R, Wang C, Liu L, et al. Autologous eytokine-indueed killer cell immunotherapy in lung cancer: A phase Ⅱ clinical study [J]. Cancer Immunol Immunother, 2012,61 ( 11 ) :2125-2133.
  • 10Li H, Wang C, Yu J, et al. Dendritic cell-activated cytokine- induced killer ceUs enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery[J ]. Cytotherapy, 2009,11 (8) : 1076-1083.

共引文献17

同被引文献18

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部